FDA Plants Oversight Flag On Amarin Trade Claim Against Omega-3 Ingredients

FDA Chief Counsel Rebecca Wood says Amarin's request for an ITC investigation necessarily turns on questions of drug and supplements policy, where it is the expert and authorized agency. If successful, Amarin's move could encourage others to similarly seek alternative forums for action.

RulesRegulationsBooks_1200x675

FDA's chief counsel cautions that Amarin Corp. PLC is asking the International Trade Commission to do the agency's work with a request that effectively would shut down a large piece of the US omega-3 dietary supplement market.

In an Oct. 6 letter asking ITC to decline considering Amarin's firm's complaint, FDA Chief Counsel Rebecca Wood...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Ingredients & Safety

More from HBW Insight